Aprecia, the 3DP Pharmaceutical Company, has named Kathi Rinesmith, R Ph, MS as its new Senior Vice President of Regulatory Affairs, it was reported on Wednesday.
Rinesmith will head the firm's regulatory strategy, objectives, policies, and programmes for the development and marketing of drug products manufactured with ZipDose Technology, the company's three-dimensional printing technology platform.
Rinesmith has over thirty years of pharmaceutical experience. Most recently, Rinesmith held the position of Director of Global Regulatory Affairs and Global Pharmacovigilance at Adare Pharmaceuticals. He has regulatory and pharmacovigilance experience in commercialised Rx, OTC, and dietary supplement products, and has served as senior executive product development and regulatory roles at Camargo Pharmaceutical Services, Prasco Laboratories, Barr Labs, and Duramed Pharmaceuticals.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer